The decision by MEPs, by 379 votes to 230, with 41 abstentions, will guarantee that some of the leading drugs in the world, developed and produced by Israel, will now reach European patients quicker and at more affordable prices. One is the Weizmann Institute's discovery of an effective vaccine for...
FULL ARTICLE AT Israel National News